Wikipedia

Pulmonary edema

(Redirected from Lung congestion)
Not to be confused with Pneumonia.

Pulmonary edema (British English: oedema), also known as pulmonary congestion, is excessive fluid accumulation in the tissue or air spaces (usually alveoli) of the lungs.[1] This leads to impaired gas exchange, most often leading to shortness of breath (dyspnea) which can progress to hypoxemia and respiratory failure. Pulmonary edema has multiple causes and is traditionally classified as cardiogenic (caused by the heart) or noncardiogenic (all other types not caused by the heart).[2][3]

Pulmonary edema
Other namesPulmonary oedema
Pulmonary edema with small pleural effusions on both sides
SpecialtyCardiology, critical care medicine pulmonology
SymptomsProgressive dyspnea, cough, fever, cyanosis, tachycardia
ComplicationsARDS, respiratory failure
CausesCardiogenic, Noncardiogenic (pneumonia, inhalation injury, sepsis, airway obstruction, high altitude)
Diagnostic methodMedical imaging, lab tests, ECG, echocardiography
TreatmentSupplemental oxygen, diuretics, treat underlying disease process

Various laboratory tests (CBC, troponin, BNP, etc.) and imaging studies (chest x-ray, CT scan, ultrasound) are often used to diagnose and classify the cause of pulmonary edema.[4][5][6]

Treatment is focused on three aspects:

  • improving respiratory function,
  • treating the underlying cause, and
  • preventing further damage and allow full recovery to the lung.

Pulmonary edema can cause permanent organ damage, and when sudden (acute), can lead to respiratory failure or cardiac arrest due to hypoxia.[7] The term edema is from the Greek οἴδημα (oidēma, "swelling"), from οἰδέω (oidéō, "(I) swell").[8][9]

Pathophysiology

edit

The amount of fluid in the lungs is governed by multiple forces and is visualized using the Starling equation. There are two hydrostatic pressures and two oncotic (protein) pressures that determine the fluid movement within the lung air spaces (alveoli). Of the forces that explain fluid movement, only the pulmonary wedge pressure is obtainable via pulmonary artery catheterization.[10] Due to the complication rate associated with pulmonary artery catheterization, other imaging modalities and diagnostic methods have become more popular.[11] Imbalance in any of these forces can cause fluid movement (or lack of movement) causing a buildup of fluid where it should not normally be. Although rarely clinically measured, these forces allow physicians to classify and subsequently treat the underlying cause of pulmonary edema.

Classification

edit

Pulmonary edema has a multitude of causes, and is typically classified as cardiogenic or noncardiogenic.

Cardiogenic pulmonary edema is caused by increased hydrostatic pressure causing increased fluid in the pulmonary interstitium and alveoli.

Noncardiogenic causes are associated with the oncotic pressure as discussed above causing malfunctioning barriers in the lungs (increased microvascular permeability).[12]

Cardiogenic

edit

Pulmonary Edema vs Congestive Heart Failure

edit

The term pulmonary edema literally means wet lungs. This term actually refers to a pathological condition of the lungs, frequently demonstrated by chest X-ray. Edema of the lungs should be thought of as the result of a disease such as congestive heart failure and not a disease in and of itself. In this case it would be a cardiac disease and not a pulmonary disease.

Cardiogenic pulmonary edema is typically caused by either volume overload or impaired left ventricular function. As a result, pulmonary venous pressures rises from the normal average of 15 mmHg.[13] As the pulmonary venous pressure rises, these pressures overwhelm the barriers and fluid enters the alveoli when the pressure is above 25 mmHg.[14] Depending on whether the cause is acute or chronic determines how fast pulmonary edema develops and the severity of symptoms.[12] Some of the common causes of cardiogenic pulmonary edema include:

  • Acute exacerbation of congestive heart failure which is due to the heart's inability to pump the blood out of the pulmonary circulation at a sufficient rate resulting in elevation in pulmonary wedge pressure and edema.
  • Pericardial tamponade as well as treating pericardial tamponade via pericardiocentesis has shown to cause pulmonary edema as a result of increased left-sided heart strain.[15]
  • Heart Valve Dysfunction such as mitral valve regurgitation can cause increased pressure and energy on the left side of the heart (increased pulmonary wedge pressure) causing pulmonary edema.[16]
  • Hypertensive crisis can cause pulmonary edema as the elevation in blood pressure and increased afterload on the left ventricle hinders forward flow in blood vessels and causes the elevation in wedge pressure and subsequent pulmonary edema. In a recent systematic review, it was found that pulmonary edema was the second most common condition associated with hypertensive crisis after ischemic stroke.[17]

Flash pulmonary edema

edit

Flash pulmonary edema is a clinical syndrome that begins suddenly and accelerates rapidly. Essentially all patients will present to the emergency department by ambulance.

The initiating acute event often a vascular event such as intense vasoconstriction and not a cardiac event such as myocardial infarction. The most noticeable abnormality is edema of the lungs. Nevertheless it is a cardiovascular disease not a pulmonary disease. It is also known by other appellations including sympathetic crashing acute pulmonary edema (SCAPE).[18] It is often associated with severe hypertension[19] Typically, patients with the syndrome of flash pulmonary edema do not have chest pain are often not recognized as having a cardiovascular disease. Treatment of FPE should include reducing systemic vascular resistance with nitroglycerin, providing supplemental oxygenation, and decreasing left ventricular filling pressure. Effective treatment is evident by a decrease in dyspnea and normalization of vital signs. Important targets of therapy such as reduced systemic vascular resistance and reduced left atrial pressure are difficult if not impossible to monitor.[20]

Recurrence of FPE is thought to be associated with hypertension[21] and may signify renal artery stenosis.[22] Prevention of recurrence is based on managing or preventing hypertension, coronary artery disease, renovascular hypertension, and heart failure.

Noncardiogenic

edit

Noncardiogenic pulmonary edema is caused by increased microvascular permeability (increased oncotic pressure) leading to increased fluid transfer into the alveolar spaces. The pulmonary artery wedge pressure is typically normal as opposed to cardiogenic pulmonary edema where the elevated pressure is causing the fluid transfer. There are multiple causes of noncardiogenic edema with multiple subtypes within each cause. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by rapid onset of widespread inflammation in the lungs. Although ARDS can present with pulmonary edema (fluid accumulation), it is a distinct clinical syndrome that is not synonymous with pulmonary edema.

Direct lung injury

edit

Acute lung injury may cause pulmonary edema directly through injury to the vasculature and parenchyma of the lung, causes include:

Indirect lung injury

edit

Special causes

edit

Some causes of pulmonary edema are less well characterized and arguably represent specific instances of the broader classifications above.

Signs and symptoms

edit
 
Fluid within the alveoli (air spaces) of the lungs

The most common symptom of pulmonary edema is dyspnea and may include other symptoms relating to inadequate oxygen (hypoxia) such as fast breathing (tachypnea), tachycardia and cyanosis. Other common symptoms include coughing up blood (classically seen as pink or red, frothy sputum), excessive sweating, anxiety, and pale skin. Other signs include end-inspiratory crackles (crackling sounds heard at the end of a deep breath) on auscultation and the presence of a third heart sound.[3]

Shortness of breath can manifest as orthopnea (inability to breathe sufficiently when lying down flat) and/or paroxysmal nocturnal dyspnea (episodes of severe sudden breathlessness at night). These are common presenting symptoms of chronic and cardiogenic pulmonary edema due to left ventricular failure.

The development of pulmonary edema may be associated with symptoms and signs of "fluid overload" in the lungs; this is a non-specific term to describe the manifestations of right ventricular failure on the rest of the body. These symptoms may include peripheral edema (swelling of the legs, in general, of the "pitting" variety, wherein the skin is slow to return to normal when pressed upon due to fluid), raised jugular venous pressure and hepatomegaly, where the liver is excessively enlarged and may be tender or even pulsatile.

Additional symptoms such as fever, low blood pressure, injuries or burns may be present and can help characterize the cause and subsequent treatment strategies.

Diagnosis

edit
 
Chest X-ray of Pulmonary Edema with lines and overlay showing congestion

There is no single test for confirming that breathlessness is caused by pulmonary edema – there are many causes of shortness of breath; but there are methods to suggest a high probability of an edema.

Lab tests

edit

Low oxygen saturation in blood and disturbed arterial blood gas readings support the proposed diagnosis by suggesting a pulmonary shunt. Blood tests are performed for electrolytes (sodium, potassium) and markers of renal function (creatinine, urea). Elevated creatine levels may suggest a cardiogenic cause of pulmonary edema.[12] Liver enzymes, inflammatory markers (usually C-reactive protein) and a complete blood count as well as coagulation studies (PT, aPTT) are also typically requested as further diagnosis. Elevated white blood cell count (WBC) may suggest a non-cardiogenic cause such as sepsis or infection.[12] B-type natriuretic peptide (BNP) is available in many hospitals, sometimes even as a point-of-care test. Low levels of BNP (<100 pg/ml) suggest a cardiac cause is unlikely, and suggest noncardiogenic pulmonary edema.[3]

Imaging tests

edit
 
Pulmonary edema on CT-scan (coronal MPR)

Chest X-ray has been used for many years to diagnose pulmonary edema due to its wide availability and relatively cheap cost.[4] A chest X-ray will show fluid in the alveolar walls, Kerley B lines, increased vascular shadowing in a classical batwing peri-hilum pattern, upper lobe diversion (biased blood flow to the superior parts instead of inferior parts of the lung), and possibly pleural effusions. In contrast, patchy alveolar infiltrates are more typically associated with noncardiogenic edema.[3]

Lung ultrasounds, employed by a healthcare provider at the point of care, is also a useful tool to diagnose pulmonary edema; not only is it accurate, but it may quantify the degree of lung water, track changes over time, and differentiate between cardiogenic and non-cardiogenic edema.[36] Lung ultrasound is recommended as the first-line method due to its wide availability, ability to be performed bedside, and wide diagnostic utility for other similar diseases.[4]

Especially in the case of cardiogenic pulmonary edema, urgent echocardiography may strengthen the diagnosis by demonstrating impaired left ventricular function, high central venous pressures and high pulmonary artery pressures leading to pulmonary edema.

Prevention

edit

In those with underlying heart or lung disease, effective control of congestive and respiratory symptoms can help prevent pulmonary edema.[37]

Dexamethasone is in widespread use for the prevention of high altitude pulmonary edema. Sildenafil is used as a preventive treatment for altitude-induced pulmonary edema and pulmonary hypertension.[38][39] Sildenafil's mechanism of action is via phosphodiesterase inhibition which raises cGMP, resulting in pulmonary arterial vasodilation and inhibition of smooth muscle cell proliferation and indirectly fluid formation in the lungs.[40] While this effect has only recently been discovered, sildenafil is already becoming an accepted treatment for this condition, in particular in situations where the standard treatment of rapid descent (acclimatization) has been delayed for some reason.[41]

Management

edit

The initial management of pulmonary edema, irrespective of the type or cause, is supporting vital functions while edema lasts. Hypoxia may require supplementary oxygen to balance blood oxygen levels, but if this is insufficient then again mechanical ventilation may be required to prevent complications caused by hypoxia.[42] Therefore, if the level of consciousness is decreased it may be required to proceed to tracheal intubation and mechanical ventilation to prevent airway compromise. Treatment of the underlying cause is the next priority; pulmonary edema secondary to infection, for instance, would require the administration of appropriate antibiotics or antivirals.[2][3]

Cardiogenic pulmonary edema

edit

Cardiogenic pulmonary edema is the result of cardiovascular insufficiency. Treatment is directed at improving cardiovascular function and providing supportive care.[43] [44] Positioning upright may relieve symptoms. A loop diuretic such as furosemide is administered, often together with morphine to reduce respiratory distress.[44] Both diuretic and morphine may have vasodilator effects, but specific vasodilators may be used (particularly intravenous glyceryl trinitrate or ISDN) provided the blood pressure is adequate.[44]

Continuous positive airway pressure and bilevel positive airway pressure (CPAP/BiPAP) has been demonstrated to reduce mortality and the need of mechanical ventilation in people with severe cardiogenic pulmonary edema.[45]

It is possible for cardiogenic pulmonary edema to occur together with cardiogenic shock, in which the cardiac output is insufficient to sustain an adequate blood pressure to the lungs. This can be treated with inotropic agents or by intra-aortic balloon pump, but this is regarded as temporary treatment while the underlying cause is addressed and the lungs recover.[44]

Prognosis

edit

As pulmonary edema has a wide variety of causes and presentations, the outcome or prognosis is often disease-dependent and more accurately described in relation to the associated syndrome. It is a major health problem, with one large review stating an incidence of 7.6% with an associated in hospital mortality rate of 11.9%.[2] Generally, pulmonary edema is associated with a poor prognosis with a 50% survival rate at one year, and 85% mortality at six years.[46]

References

edit
  1. ^ Dorland's illustrated medical dictionary (32nd ed.). Saunders/Elsevier. 2 May 2011. p. 593. ISBN 978-1-4160-6257-8.
  2. ^ a b c Assaad S, Kratzert WB, Shelley B, Friedman MB, Perrino A (April 2018). "Assessment of Pulmonary Edema: Principles and Practice" (PDF). Journal of Cardiothoracic and Vascular Anesthesia. 32 (2): 901–914. doi:10.1053/j.jvca.2017.08.028. PMID 29174750.
  3. ^ a b c d e Ware LB, Matthay MA (December 2005). "Clinical practice. Acute pulmonary edema". The New England Journal of Medicine. 353 (26): 2788–2796. doi:10.1056/NEJMcp052699. PMID 16382065.
  4. ^ a b c Lindow T, Quadrelli S, Ugander M (November 2023). "Noninvasive Imaging Methods for Quantification of Pulmonary Edema and Congestion: A Systematic Review". JACC. Cardiovascular Imaging. 16 (11): 1469–1484. doi:10.1016/j.jcmg.2023.06.023. PMID 37632500.
  5. ^ Guo L, Yang X, Yang B, Tang G, Li C (July 2023). "Prevalence, in-hospital mortality, and factors related to neurogenic pulmonary edema after spontaneous subarachnoid hemorrhage: a systematic review and meta-analysis". Neurosurgical Review. 46 (1): 169. doi:10.1007/s10143-023-02081-6. PMC 10335949. PMID 37432487.
  6. ^ Komiya K, Akaba T, Kozaki Y, Kadota JI, Rubin BK (August 2017). "A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema". Critical Care. 21 (1): 228. doi:10.1186/s13054-017-1809-8. PMC 6389074. PMID 28841896.
  7. ^ Siddiqi TJ, Usman MS, Rashid AM, Javaid SS, Ahmed A, Clark D, et al. (July 2023). "Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis". Journal of the American Heart Association. 12 (14): e029355. doi:10.1161/JAHA.122.029355. PMC 10382109. PMID 37421281.
  8. ^ οἴδημα, οἰδέω. Liddell, Henry George; Scott, Robert; A Greek–English Lexicon at the Perseus Project.
  9. ^ Harper D. "edema". Online Etymology Dictionary.
  10. ^ Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, et al. (May 2012). "ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons". Journal of the American College of Cardiology. 59 (22): 1995–2027. doi:10.1016/j.jacc.2012.03.003. PMID 22578925.
  11. ^ Rajaram SS, Desai NK, Kalra A, Gajera M, Cavanaugh SK, Brampton W, et al. (February 2013). "Pulmonary artery catheters for adult patients in intensive care". The Cochrane Database of Systematic Reviews. 2013 (2) CD003408: CD003408. doi:10.1002/14651858.CD003408.pub3. PMC 6517063. PMID 23450539.
  12. ^ a b c d e Vincent J, Moore FA, Bellomo R, Marini JJ, eds. (2024). Textbook of critical care (8th ed.). Amsterdam: Elsevier. ISBN 978-0-323-75929-8.
  13. ^ What Is Pulmonary Hypertension? From Diseases and Conditions Index (DCI). National Heart, Lung, and Blood Institute. Last updated September 2008. Retrieved on 6 April 2009.
  14. ^ Adair OV (2001). Cardiology secrets (2nd ed.). Elsevier Health Sciences. Chapter 41, page 210. ISBN 1-56053-420-6.
  15. ^ Alerhand S, Adrian RJ, Long B, Avila J (August 2022). "Pericardial tamponade: A comprehensive emergency medicine and echocardiography review". The American Journal of Emergency Medicine. 58: 159–174. doi:10.1016/j.ajem.2022.05.001. PMID 35696801. S2CID 248620419.
  16. ^ MacIver DH, Clark AL (April 2015). "The vital role of the right ventricle in the pathogenesis of acute pulmonary edema". The American Journal of Cardiology. 115 (7): 992–1000. doi:10.1016/j.amjcard.2015.01.026. PMID 25697920.
  17. ^ Siddiqi TJ, Usman MS, Rashid AM, Javaid SS, Ahmed A, Clark D, et al. (July 2023). "Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis". Journal of the American Heart Association. 12 (14): e029355. doi:10.1161/JAHA.122.029355. PMC 10382109. PMID 37421281.
  18. ^ Siddiqua N, Mathew R, Sahu AK, Jamshed N, Bhaskararayuni J, Aggarwal P, et al. (January 2024). "High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial". Emergency Medicine Journal. 41 (2): 96–102. doi:10.1136/emermed-2023-213285. PMID 38050078. S2CID 265507643.
  19. ^ Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC (January 2001). "The pathogenesis of acute pulmonary edema associated with hypertension". The New England Journal of Medicine. 344 (1): 17–22. doi:10.1056/NEJM200101043440103. PMID 11136955.
  20. ^ Long B, Koyfman A, Gottlieb M (November 2018). "Management of Heart Failure in the Emergency Department Setting: An Evidence-Based Review of the Literature". The Journal of Emergency Medicine. 55 (5): 635–646. doi:10.1016/j.jemermed.2018.08.002. PMID 30266198. S2CID 52884356.
  21. ^ Kramer K, Kirkman P, Kitzman D, Little WC (September 2000). "Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization". American Heart Journal. 140 (3): 451–455. doi:10.1067/mhj.2000.108828. PMID 10966547.
  22. ^ Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA, et al. (September 1988). "Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation". Lancet. 2 (8610): 551–552. doi:10.1016/S0140-6736(88)92668-2. PMID 2900930. S2CID 36141498.
  23. ^ Hampson NB, Dunford RG (1997). "Pulmonary edema of scuba divers". Undersea & Hyperbaric Medicine. 24 (1): 29–33. PMID 9068153. Archived from the original on 2010-06-17. Retrieved 2008-09-04.{{cite journal}}: CS1 maint: unfit URL (link)
  24. ^ Cochard G, Arvieux J, Lacour JM, Madouas G, Mongredien H, Arvieux CC (2005). "Pulmonary edema in scuba divers: recurrence and fatal outcome". Undersea & Hyperbaric Medicine. 32 (1): 39–44. PMID 15796313. Archived from the original on September 20, 2008. Retrieved 2008-09-04.{{cite journal}}: CS1 maint: unfit URL (link)
  25. ^ Kumar M, Thompson PD (May 2019). "A literature review of immersion pulmonary edema". The Physician and Sportsmedicine. 47 (2): 148–151. doi:10.1080/00913847.2018.1546104. PMID 30403902. S2CID 53209012.
  26. ^ "Transfusion-related acute lung injury (TRALI)". Professional Education. 2016-06-17. Retrieved 2016-12-03.
  27. ^ Papaioannou V, Terzi I, Dragoumanis C, Pneumatikos I (2009). "Negative-pressure acute tracheobronchial hemorrhage and pulmonary edema". Journal of Anesthesia. 23 (3): 417–420. doi:10.1007/s00540-009-0757-0. PMID 19685125. S2CID 9616605.
  28. ^ Hines, Roberta L. and Marschall, Katherine. Stoelting's Anesthesia and Co-Existing Disease. 6th edition. 2012. pages 178 and 179.
  29. ^ "Pulmonary edema". Mayo Clinic. 2018-08-08.
  30. ^ O'Leary R, McKinlay J (2011). "Neurogenic pulmonary oedema". Continuing Education in Anaesthesia, Critical Care & Pain. 11 (3): 87–92. doi:10.1093/BJACEACCP/MKR006. S2CID 18066655.
  31. ^ "Adverse Reactions". Professional Education. 2016-06-02. Archived from the original on 2016-12-20. Retrieved 2016-12-03.
  32. ^ Boyle AJ, Mac Sweeney R, McAuley DF (August 2013). "Pharmacological treatments in ARDS; a state-of-the-art update". BMC Medicine. 11: 166. doi:10.1186/1741-7015-11-166. PMC 3765621. PMID 23957905.
  33. ^ Luks AM (2008). "Do we have a "best practice" for treating high altitude pulmonary edema?". High Altitude Medicine & Biology. 9 (2): 111–114. doi:10.1089/ham.2008.1017. PMID 18578641.
  34. ^ Bates, M (2007). "High altitude pulmonary edema". Altitude Physiology Expeditions. Retrieved 2008-09-04.
  35. ^ White J, Gray M, Fisher M (1989). Atrax Robustus IPCS InChem
  36. ^ Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, et al. (April 2012). "International evidence-based recommendations for point-of-care lung ultrasound". Intensive Care Medicine. 38 (4): 577–591. doi:10.1007/s00134-012-2513-4. PMID 22392031.
  37. ^ Light RW, Lee YC (2006-01-01). "PLEURAL EFFUSIONS | Overview". In Laurent GJ, Shapiro SD (eds.). Encyclopedia of Respiratory Medicine. Oxford: Academic Press. pp. 353–358. doi:10.1016/b0-12-370879-6/00299-4. ISBN 978-0-12-370879-3.
  38. ^ Richalet JP, Gratadour P, Robach P, Pham I, Déchaux M, Joncquiert-Latarjet A, et al. (February 2005). "Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension". American Journal of Respiratory and Critical Care Medicine. 171 (3): 275–281. doi:10.1164/rccm.200406-804OC. PMID 15516532.
  39. ^ Perimenis P (May 2005). "Sildenafil for the treatment of altitude-induced hypoxaemia". Expert Opinion on Pharmacotherapy. 6 (5): 835–837. doi:10.1517/14656566.6.5.835. PMID 15934909. S2CID 24900169.
  40. ^ Clark, Michael, Kumar, Parveen J. (2009). Kumar and Clark's clinical medicine. St. Louis, Mo: Elsevier Saunders. p. 783. ISBN 978-0-7020-2993-6.
  41. ^ Fagenholz PJ, Gutman JA, Murray AF, Harris NS (2007). "Treatment of high altitude pulmonary edema at 4240 m in Nepal". High Altitude Medicine & Biology. 8 (2): 139–146. doi:10.1089/ham.2007.3055. PMID 17584008.
  42. ^ MacIntyre NR (January 2013). "Supporting oxygenation in acute respiratory failure". Respiratory Care. 58 (1): 142–150. doi:10.4187/respcare.02087. PMID 23271824.
  43. ^ Mason DT (July 1978). "Afterload reduction and cardiac performance". The American Journal of Medicine. 65 (1): 106–125. doi:10.1016/0002-9343(78)90700-3.
  44. ^ a b c d Cleland JG, Yassin AS, Khadjooi K (February 2010). "Acute heart failure: focusing on acute cardiogenic pulmonary oedema". Clinical Medicine. 10 (1): 59–64. doi:10.7861/clinmedicine.10-1-59. PMC 4954483. PMID 20408310.
  45. ^ Berbenetz N, Wang Y, Brown J, Godfrey C, Ahmad M, Vital FM, et al. (April 2019). "Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema". The Cochrane Database of Systematic Reviews. 2019 (4): CD005351. doi:10.1002/14651858.CD005351.pub4. PMC 6449889. PMID 30950507.
  46. ^ Zanza C, Saglietti F, Tesauro M, Longhitano Y, Savioli G, Balzanelli MG, et al. (October 2023). "Cardiogenic Pulmonary Edema in Emergency Medicine". Advances in Respiratory Medicine. 91 (5): 445–463. doi:10.3390/arm91050034. PMC 10604083. PMID 37887077.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pulmonary_edema&oldid=1257943890"